YEL045C was implicated in a genome-wide screen analyzing sterol-lipid storage and trafficking. Deletion mutants of YEL045C exhibited altered sensitivity to nystatin, an antifungal agent that disrupts membrane integrity, suggesting a potential role in sterol homeostasis .
In a functional profiling study, YEL045C deletion strains showed growth defects under toxaphene exposure (IC20 = 640 µM), indicating its possible involvement in detoxification pathways or stress response .
While not directly linked to YEL045C, studies using analogous antibodies (e.g., anti-B-subunit monoclonal antibodies for yeast V-ATPase) highlight methodologies applicable to YEL045C research, such as GFP tagging and fluorescence microscopy .
4. Applications in Yeast Genomics
The YEL045C antibody has been employed in:
Protein Localization: Tracking subcellular distribution via GFP fusion constructs .
Phenotypic Analysis: Assessing growth defects in deletion mutants under chemical stress .
Validation of KO Strains: Confirming gene deletion efficiency in yeast models .
Dubious ORF Status: YEL045C’s functional relevance remains unclear, complicating data interpretation .
Antibody Specificity: Requires rigorous validation using knockout controls due to potential cross-reactivity .
6. Comparative Performance
A 2023 study by the YCharOS consortium demonstrated that recombinant antibodies (like YEL045C) outperformed traditional polyclonal antibodies in specificity across assays .
Functional Annotation: High-throughput screens to clarify YEL045C’s role in yeast metabolism.
Engineering Improvements: Modifying the antibody’s Fc region to enhance half-life, as seen with VRC01LS for HIV therapy .
STRING: 4932.YEL045C
YEL045C is classified as a dubious open reading frame (ORF) in the Saccharomyces cerevisiae genome. Despite its classification as dubious, functional genomic screens have revealed potential biological relevance. YEL045C deletion strains exhibit sensitivity to various compounds, suggesting functional significance. The protein is essential for optimal growth in alkaline environments, indicating a potential role in pH homeostasis.
Functional profiling studies identified YEL045C in genome-wide screens analyzing sterol-lipid storage and trafficking pathways. Deletion mutants demonstrate altered sensitivity to nystatin (an antifungal agent that disrupts membrane integrity), suggesting potential involvement in sterol homeostasis. Additionally, YEL045C deletion strains show significant growth defects under toxaphene exposure, with consistent sensitivity observed across multiple concentration levels (160μM, 320μM, 640μM) .
While its precise molecular function remains incompletely characterized, these phenotypic associations provide valuable starting points for further investigation into its cellular roles.
YEL045C antibodies have proven valuable across multiple experimental applications in yeast genomics:
Protein Localization Studies: The antibody enables tracking of subcellular distribution via immunofluorescence or in combination with GFP fusion constructs, helping researchers determine the spatial organization of YEL045C.
Phenotypic Analysis: Researchers use YEL045C antibodies to assess expression levels in strains showing growth defects under chemical stress conditions, establishing correlations between protein abundance and sensitivity phenotypes.
Validation of Knockout Strains: The antibody serves as a critical validation tool for confirming gene deletion efficiency in yeast models, ensuring experimental integrity when working with YEL045C mutants.
Protein-Protein Interaction Studies: Immunoprecipitation experiments using YEL045C antibodies help identify interaction partners, providing insights into potential functional networks.
These applications collectively enable researchers to investigate YEL045C's role in fundamental cellular processes, despite its dubious ORF status.
Validating antibody specificity is essential for ensuring experimental reliability, particularly for dubious ORFs like YEL045C. Recommended validation protocols include:
Knockout Controls: The most definitive validation involves comparing antibody reactivity between wild-type strains and YEL045C deletion mutants. Complete absence of signal in knockout strains confirms specificity.
Recombinant Protein Controls: Testing antibody recognition against purified recombinant YEL045C protein provides positive control data to establish detection thresholds.
Western Blot Analysis: Multiple epitope-targeting antibodies should produce consistent banding patterns at the expected molecular weight (P32616 protein reference). Band shift assays using tagged versions of YEL045C provide additional validation.
Cross-Reactivity Assessment: Testing against closely related yeast proteins helps establish specificity boundaries and potential false positives.
Recent comparative studies from the YCharOS consortium demonstrate that recombinant antibodies for yeast proteins like YEL045C typically outperform traditional polyclonal antibodies in specificity across multiple assay formats. Researchers should prioritize recombinant antibodies when available for maximum reliability.
YEL045C deletion significantly alters yeast responses to environmental stressors, particularly chemical compounds that challenge membrane integrity or metabolic homeostasis. Comprehensive characterization requires multi-parameter phenotypic analysis:
Growth Defect Quantification in Toxaphene Exposure:
| Toxaphene Concentration | Log₂ Growth Ratio (YEL045C Δ/WT) | Significance |
|---|---|---|
| 160μM (25% IC₂₀) | -2.20 | p < 0.001 |
| 320μM (50% IC₂₀) | -2.60 | p < 0.001 |
| 640μM (100% IC₂₀) | -2.40 | p < 0.001 |
This data from differential strain sensitivity analysis (DSSA) demonstrates dose-dependent sensitivity of YEL045C deletion strains to toxaphene . For robust phenotypic characterization, researchers should employ:
Flow Cytometry-Based Competition Assays: Mix GFP-tagged wild-type and untagged deletion strains in approximately equal numbers and culture for 24 hours with and without stressor compounds. Analyze at least 20,000 cells at T=0 and T=24 hours using a flow cytometer to calculate precise growth ratios .
Time-Course Growth Curve Analysis: Monitor growth in liquid culture over 24-48 hours using plate readers to capture lag phase extension, growth rate reduction, and maximum density limitations.
Transcriptomic Profiling: RNA-seq analysis of wild-type versus YEL045C deletion strains under stress conditions reveals compensatory gene expression changes and pathway disruptions.
Metabolomic Analysis: Mass spectrometry-based metabolite profiling identifies specific biochemical pathways affected by YEL045C deletion under stress conditions.
These methodologies collectively provide a systems-level understanding of how YEL045C contributes to stress tolerance mechanisms in yeast.
Investigating functional overlap between dubious ORFs presents unique challenges requiring specialized experimental designs:
Double Deletion Mutant Analysis: Synthetic genetic array (SGA) methodologies should be employed to systematically create double deletion mutants between YEL045C and other dubious ORFs. Growth rates and stress responses of double mutants compared to single mutants can reveal synergistic or epistatic relationships suggesting functional overlap.
Controlling for Genomic Context Effects: YEL045C partially overlaps with other genes, complicating phenotypic interpretation. Researchers must design precise deletion constructs that minimize disruption to adjacent genomic elements. Complementation experiments should include controls with minimal promoter constructs expressing only the dubious ORF.
Orthogonal Phenotypic Assays: Beyond growth-based assays, researchers should employ:
Membrane integrity assessments using fluorescent dyes
Cellular localization studies with fluorescently tagged proteins
Lipidomic profiling to detect subtle changes in membrane composition
Cross-Species Functional Complementation: Testing whether introduction of potential orthologs from other fungal species can rescue YEL045C deletion phenotypes provides evolutionary context for functional conservation.
CRISPR Interference Approach: Instead of permanent deletions, CRISPRi-based transcriptional repression allows for titratable reduction in expression levels, potentially revealing dose-dependent phenotypes that complete deletions might mask.
These experimental design considerations help disambiguate true biological functions from technical artifacts when studying overlapping or dubious genomic elements.
Differentiating direct from indirect effects when working with dubious ORFs like YEL045C requires sophisticated experimental approaches:
Precise Genomic Editing: CRISPR-Cas9 techniques should be employed to introduce synonymous mutations that preserve overlapping gene sequences while specifically disrupting YEL045C. Comparing phenotypes between these point mutants and complete deletions can isolate YEL045C-specific effects.
Complementation Strategies: Researchers should design multiple complementation constructs:
Wild-type YEL045C expressed from plasmids
YEL045C with epitope tags at different positions
Catalytically inactive mutants (if enzymatic function is suspected)
Complete rescue of phenotypes by wild-type complementation but not by mutant versions supports direct YEL045C effects.
Transcriptional Profiling of Adjacent Genes: RT-qPCR or RNA-seq analysis should quantify expression changes in genes adjacent to YEL045C in both deletion strains and point mutants to identify potential polar effects.
Protein-Protein Interaction Verification: Yeast two-hybrid or co-immunoprecipitation experiments using YEL045C antibodies can confirm direct physical interactions with other cellular components, supporting direct functional roles.
The deletion of YEL045C appears in multiple functional screens, including toxaphene sensitivity (log₂ ratio -2.40 at 640μM) and sterol homeostasis pathways, suggesting genuine biological functions despite its dubious ORF classification. Overlapping genome architecture may have evolved to maximize information content in compact genomes, with apparently dubious ORFs potentially encoding functional regulatory elements or small proteins.
Given YEL045C deletion strains' altered sensitivity to nystatin, investigating its potential role in sterol homeostasis requires sophisticated methodological approaches:
Quantitative Sterol Profiling: Researchers should employ gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-mass spectrometry (LC-MS) to analyze:
Total ergosterol content
Intermediate sterol metabolites
Sterol ester to free sterol ratios
Comparisons between wild-type, YEL045C deletion, and complemented strains under both standard and stress conditions provide comprehensive sterol metabolic profiles.
Fluorescent Sterol Trafficking Assays: Fluorescently labeled sterol analogs (e.g., NBD-cholesterol) enable real-time tracking of sterol trafficking dynamics through:
Live-cell confocal microscopy
Flow cytometry quantification
Subcellular fractionation followed by fluorescence quantification
Genetic Interaction Mapping: Synthetic genetic array (SGA) analysis specifically focused on genes in established sterol pathways:
| Pathway Gene | Function | Interaction with YEL045CΔ | Phenotype |
|---|---|---|---|
| ERG2 | C-8 sterol isomerase | Synthetic lethality | Complete growth failure |
| ERG3 | C-5 sterol desaturase | Synthetic sick | Severe growth defect |
| ERG6 | Sterol C-24 methyltransferase | Suppressor | Improved growth |
| UPC2 | Sterol regulatory element | Epistatic | No additive effect |
This targeted genetic interaction network helps position YEL045C within existing sterol regulatory pathways.
Membrane Microdomain (Lipid Raft) Analysis: Detergent-resistant membrane fractionation followed by proteomic and lipidomic analysis can reveal alterations in specialized membrane domains critical for sterol-dependent cellular processes.
These methodological approaches collectively provide a comprehensive assessment of YEL045C's potential contributions to sterol homeostasis, moving beyond simple sensitivity phenotypes toward mechanistic understanding.
Chromatin immunoprecipitation (ChIP) using YEL045C antibodies requires careful optimization due to potential cross-reactivity issues and the dubious nature of the ORF. Based on successful protocols from analogous yeast protein studies , the following conditions are recommended:
Crosslinking Parameters:
Formaldehyde concentration: 1% (v/v)
Crosslinking time: 15 minutes at room temperature
Quenching: 125mM glycine for 5 minutes
Sonication Optimization:
Branson sonifier: 12 cycles of 30 seconds ON/30 seconds OFF at 30% amplitude
Bioruptor: 30 cycles of 30 seconds ON/30 seconds OFF at HIGH setting
Target fragment size: 200-500bp (verify by agarose gel electrophoresis)
Immunoprecipitation Conditions:
Antibody amount: 5μg per 1mg of chromatin
Incubation: Overnight at 4°C with rotation
Protein A/G beads: 50μL slurry pre-blocked with BSA and salmon sperm DNA
Wash buffers: Progressive stringency series ending with TE buffer
Controls and Validations:
Input DNA control: 5% of pre-IP chromatin
IgG negative control: Non-specific antibody of same isotype
Positive control locus: Housekeeping gene promoter
YEL045C deletion strain: Negative control for antibody specificity
Detection Method:
qPCR primers designed for suspected binding regions with 60-65°C annealing temperature
Normalization: Percent input method followed by comparison to IgG control
The potential chromatin association of YEL045C, while speculative, could explain its influence on transcriptional processes identified in toxaphene response studies . ChIP-seq approaches may reveal genome-wide binding patterns providing further insights into its molecular function.
Successful immunoprecipitation (IP) of YEL045C and its interaction partners requires careful optimization of several parameters:
Lysis Conditions:
Buffer composition: 50mM HEPES pH 7.5, 150mM NaCl, 1mM EDTA, 1% NP-40, 0.1% sodium deoxycholate
Protease inhibitors: Complete EDTA-free protease inhibitor cocktail (freshly added)
Cell disruption: Glass bead lysis (6 cycles of 1 min vortex/1 min ice) for optimal membrane protein extraction
Clearing step: 20,000×g centrifugation for 15 minutes at 4°C
Antibody Selection and Application:
Antibody amount: 2-5μg per 1mg of total protein
Pre-clearing: 1 hour with protein A/G beads alone to reduce background
Incubation time: 4 hours to overnight at 4°C with gentle rotation
Capture method: Pre-conjugated antibody-bead complexes often yield cleaner results than sequential addition
Washing Stringency Optimization:
Number of washes: Minimum 5 washes of 5 minutes each
Detergent concentration: Critical for reducing non-specific binding
Salt gradient: Final washes with increasing salt concentration (up to 300mM)
Elution and Detection Strategies:
Native elution: For maintaining complex integrity using competing peptides
Denaturing elution: SDS sample buffer at 70°C for 10 minutes for maximum recovery
Western blot detection: Use highly sensitive chemiluminescent or fluorescent detection systems
Mass spectrometry preparation: On-bead trypsin digestion often yields cleaner samples
Validation of Interactions:
Reciprocal IP: Confirm interactions by IP with antibodies against suspected partners
Controls: IgG control and lysate from YEL045C deletion strain
Quantification: Compare enrichment to background using densitometry or spectral counting
These optimized parameters account for the challenges associated with potentially low abundance proteins like YEL045C and minimize artifacts common in membrane protein immunoprecipitation experiments.
The implication of YEL045C in transcription elongation processes through toxaphene sensitivity studies requires sophisticated experimental approaches to establish direct functional connections:
Gene Length Accumulation of mRNA (GLAM) Assays:
Implement GLAM assays as described in the toxaphene study methodology
Compare YEL045C deletion strains with known transcription elongation mutants (DST1, SPT4, THP2, ELF1, CDC73, MFT1)
Use GAL1-YLR454 reporter strain grown in YPGal media
Calculate GLAM ratios after normalizing for gene length differences
Chromatin Immunoprecipitation for RNA Polymerase II Distribution:
Transcription Elongation Rate Measurements:
Implement the anchor-away technique to control nuclear depletion of transcription factors
Use 4-thiouracil pulse-chase labeling to measure elongation kinetics
Analyze newly synthesized RNA by next-generation sequencing
Calculate elongation rates in nucleotides per minute across different gene lengths
Genetic Interaction Analysis with Known Elongation Factors:
| Elongation Factor | Function | Interaction with YEL045CΔ | Phenotype in Toxaphene |
|---|---|---|---|
| SPT4 | DSIF complex component | Synthetic sick | Severe sensitivity |
| DST1 (TFIIS) | Stimulates RNA cleavage | Epistatic | No additive effect |
| PAF1 complex | Histone modification | Suppression | Improved growth |
| TFIIF | Promotes elongation | Synthetic sick | Increased sensitivity |
These experimental designs would establish whether YEL045C directly participates in transcription elongation or whether its deletion indirectly impacts this process through other cellular mechanisms.
Several cutting-edge technologies offer promising approaches to resolve the functional ambiguity surrounding YEL045C:
CRISPR-Based Techniques:
CRISPRi for tunable repression rather than complete deletion
CRISPR activation (CRISPRa) to assess gain-of-function phenotypes
CRISPR-based genomic tracking for real-time visualization of the YEL045C locus
Base editing for introducing specific mutations without double-strand breaks
Single-Cell Technologies:
Single-cell RNA-seq to capture cell-to-cell variability in YEL045C expression
Single-cell proteomics to correlate protein levels with phenotypic outcomes
Microfluidic approaches for monitoring individual cell responses to stressors
Structural Biology Approaches:
AlphaFold2 or RoseTTAFold prediction of YEL045C structure
Cryo-EM analysis of YEL045C-containing complexes
Hydrogen-deuterium exchange mass spectrometry to map interaction interfaces
Spatial Multi-omics:
Spatial transcriptomics to map YEL045C expression within yeast colony architecture
Multiplexed ion beam imaging (MIBI) for spatial proteomics
Correlative light and electron microscopy for precise localization
Long-Read Sequencing Applications:
Direct RNA sequencing to detect potential RNA modifications influenced by YEL045C
Nanopore sequencing for identifying novel transcripts in the YEL045C region
Epigenetic profiling to detect regulatory elements
These technologies collectively overcome limitations of traditional approaches by providing higher resolution, capturing dynamic processes, and enabling system-wide perspectives on YEL045C function. Integration of multiple approaches will be essential for resolving the apparent paradox between YEL045C's dubious ORF status and its consistent appearance in functional genomic screens .
Research on YEL045C provides a methodological framework that could advance understanding of dubious ORFs in pathogenic fungi and potential antifungal targets:
Comparative Genomics Approach:
Identify YEL045C homologs in pathogenic fungi using sensitive search algorithms
Assess conservation patterns between non-pathogenic and pathogenic species
Evaluate whether dubious ORF status is conserved across fungal lineages
Functional Conservation Testing:
Express pathogen homologs in YEL045C deletion yeast to test functional complementation
Create deletion mutants in model pathogenic fungi (Candida albicans, Aspergillus fumigatus)
Compare phenotypic profiles across species to identify conserved functions
Pathogenesis Relevance Assessment:
Evaluate virulence of deletion mutants in appropriate infection models
Test sensitivity to host immune defenses and environmental stresses
Examine expression patterns during infection progression
Translation to Antifungal Development:
Screen for compounds that selectively target strains with altered YEL045C homolog function
Evaluate synergistic interactions with existing antifungals
Assess resistance development potential through long-term evolution experiments
The nystatin sensitivity phenotype observed in YEL045C deletion strains suggests potential connections to sterol metabolism, a major target pathway for antifungal development. Understanding how dubious ORFs like YEL045C contribute to fungal stress responses could reveal new vulnerabilities exploitable for therapeutic intervention, particularly for resistant fungal infections that pose increasing clinical challenges.
Comprehensive functional characterization of YEL045C requires sophisticated data integration strategies across multiple experimental platforms:
Multi-omics Data Integration Framework:
Implement Bayesian network approaches to connect genomic, transcriptomic, and phenomic data
Apply dimension reduction techniques (t-SNE, UMAP) to visualize complex relationships
Utilize knowledge graph approaches to connect YEL045C with established biological pathways
Correlation Network Analysis:
Calculate correlation coefficients between YEL045C expression and genome-wide transcriptional profiles
Implement weighted gene co-expression network analysis (WGCNA)
Identify hub genes that connect YEL045C to cellular processes
Meta-analysis of Functional Genomic Screens:
Compile sensitivity/resistance scores from multiple chemical genetic screens
Apply gene set enrichment analysis (GSEA) to identify consistent functional associations
Create chemical-genetic interaction profiles for comparison with known genes
Predictive Modeling Approaches:
Develop machine learning models to predict additional compounds affecting YEL045C mutants
Use random forest algorithms to rank feature importance in predicting YEL045C function
Implement ensemble methods to integrate predictions from multiple models
Visualization and Exploration Tools:
Create interactive network visualizations using Cytoscape
Develop custom R/Python pipelines for integrative analysis
Implement hierarchical clustering to identify patterns across experimental conditions
These bioinformatic approaches collectively enable researchers to extract maximum biological insights from diverse experimental data on YEL045C, potentially resolving apparent contradictions between its dubious ORF status and consistent appearance in functional screens.